Cancer Survivor Marks 7 Years in Remission Thanks to CAR‑T Therapy

Published on LinkedIn via Laurie Adami

Laurie Adami shared her 7-year remission milestone after receiving Yescarta CAR‑T therapy in a phase 2 clinical trial at UCLA. Following 12 years of failed treatments for follicular non‑Hodgkin lymphoma, this was her seventh therapy and the one that put her into lasting remission. Now considered cured of what was once labeled incurable, she continues to raise awareness for this life-changing cell therapy and the academic research teams that made it possible.

Read the full article on LinkedIn:

👉 7 years post CAR‑T therapy and still in remission

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link.